Asston Pharmaceuticals IPO to list today. GMP signals healthy premium on debut

Asston Pharmaceuticals is launching on the Bombay Stock Exchange SME platform this Wednesday. The initial public offering saw strong interest. The company manufactures and exports various pharmaceutical products. Asston focuses on analgesics, antibiotics and vitamins. The company reported revenue growth in fiscal year 2025. Investors are watching the stock's opening price closely.